Lancet. 1991 Apr 27;337(8748):998-1001.

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine.

Rickman LS, Gordon DM, Wistar R Jr, Krzych U, Gross M, Hollingdale MR, Egan JE, Chulay JD, Hoffman SL.

Source

Division of Infectious Diseases, National Naval Medical Center, Bethesda, Maryland 20852.

Abstract

Human immune responses to modern synthetic and recombinant peptide vaccines administered with the standard adjuvant, aluminum hydroxide, tend to be poor, hence the search for better adjuvants. Antibody responses to a Plasmodium falciparum circumsporozoite (CS) protein vaccine, R32NS1(81), administered with an adjuvant containing cell-wall skeleton of mycobacteria and monophosphoryl lipid A in squalane (MPL/CWS) have been compared to responses to the same immunogen administered with aluminum hydroxide. 2 weeks after the third dose the following indices were greater in the 5 patients who received MPL/CWS than in controls (p less than 0.05): the geometric mean concentration (2.0 vs 25.4 microgram/ml) and avidity index of antibodies to the P falciparum CS protein by ELISA, the geometric mean titre to P falciparum sporozoites by IFAT (1/115 vs 1/1600), and the geometric mean inhibition of sporozoite invasion of hepatoma cells in vitro (37.6 vs 90.3%). For R32NS1(81) MPL/CWS is superior to aluminum hydroxide as an adjuvant, and the data support the evaluation of this complex as an adjuvant for other vaccines.

PMID:: 1673211; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant. [Am J Trop Med Hyg. 1994]
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.
Hoffman SL, Edelman R, Bryan JP, Schneider I, Davis J, Sedegah M, Gordon D, Church P, Gross M, Silverman C. Am J Trop Med Hyg. 1994 Nov; 51(5):603-12.
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. [Proc Natl Acad Sci U S A. 1992]
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.
Fries LF, Gordon DM, Richards RL, Egan JE, Hollingdale MR, Gross M, Silverman C, Alving CR. Proc Natl Acad Sci U S A. 1992 Jan 1; 89(1):358-62.
Review Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. [Immunol Lett. 1990]
Review Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.
Alving CR, Richards RL. Immunol Lett. 1990 Aug; 25(1-3):275-9.
Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers. [Vaccine. 2002]
Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
Vernacchio L, Bernstein H, Pelton S, Allen C, MacDonald K, Dunn J, Duncan DD, Tsao G, LaPosta V, Eldridge J, et al. Vaccine. 2002 Nov 1; 20(31-32):3658-67.
Review Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. [Adv Exp Med Biol. 2009]
Review Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.
Cluff CW. Adv Exp Med Biol. 2009; 667:111-23.

See reviews... See all...

Cited by 16 PubMed Central articles

Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts. [Clin Vaccine Immunol. 2008]
Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts.
Hui G, Choe D, Hashimoto C. Clin Vaccine Immunol. 2008 Aug; 15(8):1145-50. Epub 2008 Jun 18.
Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants. [Infect Immun. 2000]
Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.
Aebischer T, Wolfram M, Patzer SI, Ilg T, Wiese M, Overath P. Infect Immun. 2000 Mar; 68(3):1328-36.
Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. [Infect Immun. 1998]
Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.
Sasaki S, Hamajima K, Fukushima J, Ihata A, Ishii N, Gorai I, Hirahara F, Mohri H, Okuda K. Infect Immun. 1998 Feb; 66(2):823-6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipi...
Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine.
Lancet. 1991 Apr 27 ;337(8748):998-1001.

PubMed
Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosc...
Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate.
Atherosclerosis. 1989 Apr ;76(2-3):155-61.

PubMed
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation ...
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
Genes Dev. 1996 Sep 1 ;10(17):2105-16.

PubMed
A randomized controlled trial of an HIV sexual risk-reduction intervention for y...
A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women.
JAMA. 1995 Oct 25 ;274(16):1271-6.

PubMed
Uniform requirements for manuscripts submitted to biomedical journals. Internati...
Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors.
Ann Intern Med. 1997 Jan 1 ;126(1):36-47.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Cited by 16 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information